In the News

Share
1663 News Items found
Bob Li, MD, PhD, MPH
First-Ever KRAS Inhibitor Gets Accelerated Approval for Non-Small Cell Lung Cancer
Memorial Sloan Kettering’s Bob Li served as principal investigator of the CodeBreaK 100 trial, the largest clinical trial conducted to date exclusively for patients with the KRAS G12C mutation.
Feature
Riya Agrawal
More Than a Field Trip: MSK Radiologists Mentor High School Students
Each year, MSK offers a one-day radiology intensive and six-week paid internships to high school students across New York City.
Adelle Vice, MSK Registered Nurse
MSK Takes Home Silver Award in 2021 Campaign US Media Awards
Memorial Sloan Kettering (MSK)’s Department of Marketing & Communications was awarded the Silver Award for Most Effective Media Plan in the 2021 Campaign US Media Awards.
Sloan Kettering Institute immunologists Joseph Sun and Sam Sheppard
SKI Scientists Learn What Fuels the ‘Natural Killers’ of the Immune System
Sloan Kettering Institute scientists are understanding more about natural killer (NK) cells, which are your allies when it comes to fighting infections and cancer.
Rev. Paul Yoon holding his infant son and standing with his wife
MSK Reverend Paul Yoon: Healing a Wounded World with Compassion
Meet Paul Yoon, Program Coordinator of Spiritual Care at Memorial Sloan Kettering, who immigrated to the US from South Korea, survived cancer, and is navigating his concerns around violence against Asian Americans.
Memorial Sloan Kettering medical oncologist Michael Morris
Finding Hidden Cancer Cells: FDA Approval of New Imaging Tool Could Transform Treatment Decisions for Advanced Prostate Cancer
A newly approved imaging technology can identify the location of prostate cancer cells, allowing doctors to choose the best treatment.
In the Lab
Illustration of a fish inside a bubble-like structure. The fish has strands of genetic material coming from its mouth. Outside the bubble is a worm-like creature with an open mouth, ready to gobble up the fish.
Researchers Discover New Cancer Cell Vulnerability: Droplets in the Nucleus
SKI researchers have learned how tiny droplets prevent a cancer-causing type of messenger RNA from being degraded in leukemia cells.
MSK-IMPACT
The National Cancer Act @ 50: Reflecting on Half a Century of Cancer Research
Fifty years ago, the signing of the National Cancer Act ushered in a new era of cancer research and care.
A video of a developing mouse embryo
Super Vision: How New Imaging Technologies Are Transforming Biomedical Research
With the power of advanced microscopes, Sloan Kettering Institutes scientists are pushing the boundaries of what can be seen and measured.
Cornelius Taabazuing
From a Village in Ghana to a Rising Young Researcher: Cornelius Taabazuing Reflects on His Journey
Learn about the journey of Cornelius Taabazuing, a rising young scientist who recently won the Tri-Institute Breakout Award for Young Investigators at the Sloan Kettering Institute.